The German News Network
SEE OTHER BRANDS

The top news stories from Germany

The German News Network: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The German News Network.

Press releases published on May 27, 2025

BioNTech to Present Progress Across Diversified Oncology Pipeline at the 2025 ASCO Annual Meeting

BioNTech to Present Progress Across Diversified Oncology Pipeline at the 2025 ASCO Annual Meeting

MAINZ, Germany, May 27, 2025 -- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will present clinical trial data from select pipeline candidates across the Company’s diversified oncology portfolio at the American Society of Clinical Oncology (“ASCO …

Strüngmann Award ehrt herausragende Life-Science-Unternehmerinnen und Unternehmer aus der DACH-Region und gibt 2025 Finalisten bekannt

Strüngmann Award ehrt herausragende Life-Science-Unternehmerinnen und Unternehmer aus der DACH-Region und gibt 2025 Finalisten bekannt

Die diesjährigen Finalistinnen und Finalisten überzeugten durch unternehmerische Exzellenz und großes Innovationspotenzial ihrer therapeutischen Ansätze über unterschiedliche wissenschaftliche Fachrichtungen hinweg Das Gewinnerteam wird am 3. Juli 2025 …

Strüngmann Award Committee Announces 2025 Finalists Recognizing Outstanding Life Science Entrepreneurs in the DACH Region

Strüngmann Award Committee Announces 2025 Finalists Recognizing Outstanding Life Science Entrepreneurs in the DACH Region

The selected finalists have demonstrated entrepreneurial execution and translational potential for a range of scientific approaches The winner(s) will be officially announced on July 3, 2025, and will receive an EUR 100,000 cash prize Munich, Germany, May …

ITM Secures Up to $262.5m in Non-dilutive Debt Financing with Blue Owl Managed Funds

ITM Secures Up to $262.5m in Non-dilutive Debt Financing with Blue Owl Managed Funds

Debt capital to support commercial readiness and potential U.S. launch of n.c.a. 177Lu-edotreotide (ITM-11), following positive Phase 3 results Flexible funding structure enables continued advancement of ITM’s targeted radiopharmaceutical pipeline and …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service